InnoPhysics has joined the REGMED XB initiative. REGMED XB aims at three 'moonshot' developments in regenerative medicine: taking steps towards bioengineerd joints, a first subunit of a bioengineered kidney, proof-of-concept therapy for type I diabetes. Innophysics will assisted the researchers to provide solutions where cells meet surfaces.
The REGMED XB program was officially launched on the 30th of March 2017 at the Leiden University.
For more information see https://www.regmedxb.com/